CDC Data More Positive on Myocarditis Benefit-Risk Than FDA’s Assessment of Pfizer’s Vaccine

 
• By Sarah Karlin-Smith

Updated modeling on heart events in young adults presented to CDC’s vaccine advisors points towards much lower rates of the adverse event from mRNA vaccines than some of FDA’s modeling.

cardio-covid scales (nielsen hobbs)
In weighing the risks of myocarditis versus the risks of COVID-19, one key difference between CDC’s modeling and FDA’s “worst-case” scenario is that CDC relied on VAERS, while FDA’s used Optum’s US claims database. • Source: Nielsen Hobbs

More from Vaccines

More from Pink Sheet